Alejandro Enriquez-Marulanda

Alejandro Enriquez-Marulanda

Auto-generated profile, based on publicly available information

Alejandro Enriquez-Marulanda

Neurosurgical Division, Beth Israel Deaconess Medical Center, Boston, MA, United States; Harvard Medical School, Boston, MA, United States

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2021 in Neurosurgery
Verified
Journal Article
Closed access
AEAlejandro Enriquez-Marulanda
Alejandro Enriquez-Marulanda
SGSantiago Gomez-Paz
Santiago Gomez-Paz
MSMohamed M Salem
Mohamed M Salem
AMAkashleena Mallick
Akashleena Mallick
RMRouzbeh Motiei-Langroudi
Rouzbeh Motiei-Langroudi
ATAjith J Thomas
Ajith J Thomas
BACKGROUND: Middle meningeal artery (MMA) embolization is an emerging minimally invasive endovascular technique for chronic subdural hematoma (cSDH). Currently, limited literature exists on its safety and efficacy compared with conventional treatment (open-surgical-evacuation-only). OBJECTIVE: To compare MMA embolization to conventional treatment. METHODS: Retrospective analysis of patients with cSDHs treated with MMA embolization in a single center from 2018 to 2019 was performed. Comparisons were made with a historical conventional treatment cohort from 2006 to 2016. Propensity score matching analysis was used to assemble a balanced group of subjects. RESULTS: A total of 357 conventionally treated cSDH and 45 with MMA embolization were included. After balancing with propensity score matching, a total of 25 pairs of cSDH were analyzed. Comparing the embolization with the conventional treatment group yielded no significant differences in complications (4% vs 4%; P > .99), clinical improvement (82.6% vs 83.3%; P = .95), cSDH recurrence (4.3% vs 21.7%; P = .08), overall re-intervention rates (12% vs 24%; P = .26), modified Rankin scale >2 on last follow-up (17.4% vs 32%; P = .24), as well as mortality (0% vs 12%; P = .09). Radiographic improvement at last follow-up was significantly higher in the open surgery cohort (73.9% vs 95.6%; P = .04). However, there was a trend for lengthier last follow-up for the historical cohort (72 vs 104 d; P = .07). CONCLUSION: There was a trend for lower recurrence and mortality rates in the embolization era cohort. There were significantly higher radiological improvement rates on last follow-up in the surgical only cohort era. There were no significant differences in complications and clinical improvement.

1 May 2020 in Journal of Neurosurgery
Verified
Journal Article
Closed access
PDF file
GMGeorgios A. Maragkos
Georgios A. Maragkos
LALuis C. Ascanio
Luis C. Ascanio
MSMohamed M. Salem
Mohamed M. Salem
SGSricharan Gopakumar
Sricharan Gopakumar
SGSantiago Gomez-Paz
Santiago Gomez-Paz
ATAjith J. Thomas
Ajith J. Thomas
OBJECTIVE: The Pipeline embolization device (PED) is a routine choice for the endovascular treatment of select intracranial aneurysms. Its success is based on the high rates of aneurysm occlusion, followed by near-zero recanalization probability once occlusion has occurred. Therefore, identification of patient factors predictive of incomplete occlusion on the last angiographic follow-up is critical to its success.METHODS: A multicenter retrospective cohort analysis was conducted on consecutive patients treated with a PED for unruptured aneurysms in 3 academic institutions in the US. Patients with angiographic follow-up were selected to identify the factors associated with incomplete occlusion.RESULTS: Among all 3 participating institutions a total of 523 PED placement procedures were identified. There were 284 procedures for 316 aneurysms, which had radiographic follow-up and were included in this analysis (median age 58 years; female-to-male ratio 4.2:1). Complete occlusion (100% occlusion) was noted in 76.6% of aneurysms, whereas incomplete occlusion (≤ 99% occlusion) at last follow-up was identified in 23.4%. After accounting for factor collinearity and confounding, multivariable analysis identified older age (> 70 years; OR 4.46, 95% CI 2.30–8.65, p < 0.001); higher maximal diameter (≥ 15 mm; OR 3.29, 95% CI 1.43–7.55, p = 0.005); and fusiform morphology (OR 2.89, 95% CI 1.06–7.85, p = 0.038) to be independently associated with higher rates of incomplete occlusion at last follow-up. Thromboembolic complications were noted in 1.4% and hemorrhagic complications were found in 0.7% of procedures.CONCLUSIONS: Incomplete aneurysm occlusion following placement of a PED was independently associated with age > 70 years, aneurysm diameter ≥ 15 mm, and fusiform morphology. Such predictive factors can be used to guide individualized treatment selection and counseling in patients undergoing cerebrovascular neurosurgery.

20 February 2020 in Neurosurgery
Verified
Journal Article
Closed access
LALuis C Ascanio
Luis C Ascanio
AEAlejandro Enriquez-Marulanda
Alejandro Enriquez-Marulanda
GMGeorgios A Maragkos
Georgios A Maragkos
MSMohamed M Salem
Mohamed M Salem
AAAbdulrahman Y Alturki
Abdulrahman Y Alturki
JMJustin M Moore
Justin M Moore
BACKGROUND: The association of blood pressure variation with poor outcomes in aneurysmal subarachnoid hemorrhage (aSAH) is unknown. OBJECTIVE: To evaluate the association of systolic blood pressure (SBP) variation and clinical outcomes in aSAH. METHODS: We conducted a retrospective chart review of all aSAH patients treated at an academic institution between 2007 and 2016. Patient demographics, aSAH characteristics, and blood pressure observations for the first 24 h of admission in 4-h intervals were obtained. SBP variability metrics assessed were mean, standard deviation, maximum, minimum, peak, trough, coefficient of variation, and successive variation. The primary outcome was a composite of the modified Rankin scale as good (0-2) or poor (3-6) at last follow-up. Comparisons between outcome groups were performed. Logistic regression models for each significant SBP metric controlling for potential confounders were constructed. RESULTS: The study population was 202 patients. The mean age was 57 yr; 66% were female. The median follow-up time was 18 mo; 57 (29%) patients had a poor outcome. Patients with poor outcomes had higher standard deviation (17.1 vs 14.7 mmHg, P = .01), peak (23.5 vs 20.0 mmHg, P = .02), trough (22.6 vs 19.2 mmHg, P < .01), coefficient of variation (13.9 vs 11.8 mmHg, P < .01), and lower minimum SBP (101.4 vs 108.4, P < .01). The logistic regression showed that every 1-mmHg increase in the minimum SBP increased the odds of good outcomes (odds ratio = 1.03; 95% CI = 1.001-1.064; P = .04). Models including other SBP metrics were not significant. CONCLUSION: Hypotension was found to be independently associated with poor outcomes in patients with aSAH.

1 December 2018 in World Neurosurgery
Verified
Journal Article
Closed access
KRKrishnan Ravindran
Krishnan Ravindran
MSMohamed M. Salem
Mohamed M. Salem
AEAlejandro Enriquez-Marulanda
Alejandro Enriquez-Marulanda
AAAbdulrahman Y. Alturki
Abdulrahman Y. Alturki
JMJustin M. Moore
Justin M. Moore
COChristopher S. Ogilvy
Christopher S. Ogilvy

1 November 2017 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
AEAlejandro Enriquez-Marulanda
Alejandro Enriquez-Marulanda
JVJaime Valderrama-Chaparro
Jaime Valderrama-Chaparro
LPLaura Parrado
Laura Parrado
JVJuan Diego Vélez
Juan Diego Vélez
AGAna Maria Granados
Ana Maria Granados
JQJairo Quiñones
Jairo Quiñones

12 December 2018 in Neurosurgery
Verified
Journal Article
Closed access
CGChristoph J Griessenauer
Christoph J Griessenauer
ATAjith J Thomas
Ajith J Thomas
AEAlejandro Enriquez-Marulanda
Alejandro Enriquez-Marulanda
ADAviraj Deshmukh
Aviraj Deshmukh
AJAbhi Jain
Abhi Jain
MKMonika Killer-Oberpfalzer
Monika Killer-Oberpfalzer
BACKGROUND: Flow diversion has become an accepted endovascular treatment modality for intracranial aneurysms. Studies comparing different types of flow diverters are currently lacking. OBJECTIVE: To perform a propensity score-matched cohort study comparing the Pipeline Embolization Device (PED; Medtronic, Dublin, Ireland) and Flow Redirection Endoluminal Device (FRED; MicroVention, Aliso Viejo, California). METHODS: Aneurysms of the internal carotid artery proximal to the communicating segment treated with PED at 2 neurovascular centers in the United States were matched with aneurysms treated in the European FRED study using propensity scoring. Aneurysms treated in the setting of subarachnoid hemorrhage were excluded from matching. Occlusion rates and complications were evaluated. RESULTS: Two hundred twenty-one internal carotid artery aneurysms were treated with PED and 282 with FRED. Propensity score matching controlling for age, sex, aneurysm size, location, number of flow diverters, and adjunctive coiling resulted in 55 matched pairs. Median angiographic follow-up was nonsignificantly longer for FRED compared to PED (12.2 vs 7.5 mo, P = .28). The rate of complete occlusion did not differ between flow diverters (80% vs 80%, P > .99). Functional outcome and complications were comparable for PED and FRED. CONCLUSION: Propensity score-matched analysis of PED and FRED for internal carotid artery aneurysms revealed comparable angiographic complete occlusion and complication rates. Whether FRED has an advantage in terms of near complete aneurysm occlusion warrants further investigation. Limitations include the retrospective design and lack of an independent assessment of radiographic outcome in a core-laboratory and functional outcomes, among others, and the results should be interpreted as such.